Industry Research Reports

Home > Reports > Pharma & Healthcare > Indapamide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Indapamide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 130 Pages

Report ld: 2340341

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Indapamide was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Indapamide was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Indapamide was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Indapamide was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Indapamide include Servier, Cigna, ANI Pharma, Mylan, Teva, Shandong Yinfeida Pharmaceutical, Taj Pharmaceuticals, Supra Chemicals and Glenmark Pharmaceuticals, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Indapamide, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Indapamide by region & country, by Type, and by Application.

The Indapamide market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Indapamide.

Market Segmentation

Report Metric
Details
Report Title
Indapamide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Indapamide Companies Covered
Servier, Cigna, ANI Pharma, Mylan, Teva, Shandong Yinfeida Pharmaceutical, Taj Pharmaceuticals, Supra Chemicals, Glenmark Pharmaceuticals, Suzhou Lixinpharm, Lisheng Pharma, Apeloa Kangyu
Global Indapamide Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Indapamide Market, Segment by Type
1.25 mg Indapamide Tablets

2.5 mg Indapamide Tablets
Global Indapamide Market, Segment by Application
Diuretic

Hypertension Treatment

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Indapamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Indapamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Indapamide in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Indapamide Product Introduction
    1.2 Global Indapamide Market Size Forecast
        1.2.1 Global Indapamide Sales Value (2019-2030)
        1.2.2 Global Indapamide Sales Volume (2019-2030)
        1.2.3 Global Indapamide Sales Price (2019-2030)
    1.3 Indapamide Market Trends & Drivers
        1.3.1 Indapamide Industry Trends
        1.3.2 Indapamide Market Drivers & Opportunity
        1.3.3 Indapamide Market Challenges
        1.3.4 Indapamide Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Indapamide Players Revenue Ranking (2023)
    2.2 Global Indapamide Revenue by Company (2019-2024)
    2.3 Global Indapamide Players Sales Volume Ranking (2023)
    2.4 Global Indapamide Sales Volume by Company Players (2019-2024)
    2.5 Global Indapamide Average Price by Company (2019-2024)
    2.6 Key Manufacturers Indapamide Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Indapamide Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Indapamide
    2.9 Indapamide Market Competitive Analysis
        2.9.1 Indapamide Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Indapamide Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Indapamide as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 1.25 mg Indapamide Tablets
        3.1.2 2.5 mg Indapamide Tablets
    3.2 Global Indapamide Sales Value by Type
        3.2.1 Global Indapamide Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Indapamide Sales Value, by Type (2019-2030)
        3.2.3 Global Indapamide Sales Value, by Type (%) (2019-2030)
    3.3 Global Indapamide Sales Volume by Type
        3.3.1 Global Indapamide Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Indapamide Sales Volume, by Type (2019-2030)
        3.3.3 Global Indapamide Sales Volume, by Type (%) (2019-2030)
    3.4 Global Indapamide Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Diuretic
        4.1.2 Hypertension Treatment
        4.1.3 Other
    4.2 Global Indapamide Sales Value by Application
        4.2.1 Global Indapamide Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Indapamide Sales Value, by Application (2019-2030)
        4.2.3 Global Indapamide Sales Value, by Application (%) (2019-2030)
    4.3 Global Indapamide Sales Volume by Application
        4.3.1 Global Indapamide Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Indapamide Sales Volume, by Application (2019-2030)
        4.3.3 Global Indapamide Sales Volume, by Application (%) (2019-2030)
    4.4 Global Indapamide Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Indapamide Sales Value by Region
        5.1.1 Global Indapamide Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Indapamide Sales Value by Region (2019-2024)
        5.1.3 Global Indapamide Sales Value by Region (2025-2030)
        5.1.4 Global Indapamide Sales Value by Region (%), (2019-2030)
    5.2 Global Indapamide Sales Volume by Region
        5.2.1 Global Indapamide Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Indapamide Sales Volume by Region (2019-2024)
        5.2.3 Global Indapamide Sales Volume by Region (2025-2030)
        5.2.4 Global Indapamide Sales Volume by Region (%), (2019-2030)
    5.3 Global Indapamide Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Indapamide Sales Value, 2019-2030
        5.4.2 North America Indapamide Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Indapamide Sales Value, 2019-2030
        5.5.2 Europe Indapamide Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Indapamide Sales Value, 2019-2030
        5.6.2 Asia Pacific Indapamide Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Indapamide Sales Value, 2019-2030
        5.7.2 South America Indapamide Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Indapamide Sales Value, 2019-2030
        5.8.2 Middle East & Africa Indapamide Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Indapamide Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Indapamide Sales Value
        6.2.1 Key Countries/Regions Indapamide Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Indapamide Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Indapamide Sales Value, 2019-2030
        6.3.2 United States Indapamide Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Indapamide Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Indapamide Sales Value, 2019-2030
        6.4.2 Europe Indapamide Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Indapamide Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Indapamide Sales Value, 2019-2030
        6.5.2 China Indapamide Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Indapamide Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Indapamide Sales Value, 2019-2030
        6.6.2 Japan Indapamide Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Indapamide Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Indapamide Sales Value, 2019-2030
        6.7.2 South Korea Indapamide Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Indapamide Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Indapamide Sales Value, 2019-2030
        6.8.2 Southeast Asia Indapamide Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Indapamide Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Indapamide Sales Value, 2019-2030
        6.9.2 India Indapamide Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Indapamide Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Servier
        7.1.1 Servier Company Information
        7.1.2 Servier Introduction and Business Overview
        7.1.3 Servier Indapamide Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Servier Indapamide Product Offerings
        7.1.5 Servier Recent Development
    7.2 Cigna
        7.2.1 Cigna Company Information
        7.2.2 Cigna Introduction and Business Overview
        7.2.3 Cigna Indapamide Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Cigna Indapamide Product Offerings
        7.2.5 Cigna Recent Development
    7.3 ANI Pharma
        7.3.1 ANI Pharma Company Information
        7.3.2 ANI Pharma Introduction and Business Overview
        7.3.3 ANI Pharma Indapamide Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 ANI Pharma Indapamide Product Offerings
        7.3.5 ANI Pharma Recent Development
    7.4 Mylan
        7.4.1 Mylan Company Information
        7.4.2 Mylan Introduction and Business Overview
        7.4.3 Mylan Indapamide Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Mylan Indapamide Product Offerings
        7.4.5 Mylan Recent Development
    7.5 Teva
        7.5.1 Teva Company Information
        7.5.2 Teva Introduction and Business Overview
        7.5.3 Teva Indapamide Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Teva Indapamide Product Offerings
        7.5.5 Teva Recent Development
    7.6 Shandong Yinfeida Pharmaceutical
        7.6.1 Shandong Yinfeida Pharmaceutical Company Information
        7.6.2 Shandong Yinfeida Pharmaceutical Introduction and Business Overview
        7.6.3 Shandong Yinfeida Pharmaceutical Indapamide Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Shandong Yinfeida Pharmaceutical Indapamide Product Offerings
        7.6.5 Shandong Yinfeida Pharmaceutical Recent Development
    7.7 Taj Pharmaceuticals
        7.7.1 Taj Pharmaceuticals Company Information
        7.7.2 Taj Pharmaceuticals Introduction and Business Overview
        7.7.3 Taj Pharmaceuticals Indapamide Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Taj Pharmaceuticals Indapamide Product Offerings
        7.7.5 Taj Pharmaceuticals Recent Development
    7.8 Supra Chemicals
        7.8.1 Supra Chemicals Company Information
        7.8.2 Supra Chemicals Introduction and Business Overview
        7.8.3 Supra Chemicals Indapamide Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Supra Chemicals Indapamide Product Offerings
        7.8.5 Supra Chemicals Recent Development
    7.9 Glenmark Pharmaceuticals
        7.9.1 Glenmark Pharmaceuticals Company Information
        7.9.2 Glenmark Pharmaceuticals Introduction and Business Overview
        7.9.3 Glenmark Pharmaceuticals Indapamide Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Glenmark Pharmaceuticals Indapamide Product Offerings
        7.9.5 Glenmark Pharmaceuticals Recent Development
    7.10 Suzhou Lixinpharm
        7.10.1 Suzhou Lixinpharm Company Information
        7.10.2 Suzhou Lixinpharm Introduction and Business Overview
        7.10.3 Suzhou Lixinpharm Indapamide Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Suzhou Lixinpharm Indapamide Product Offerings
        7.10.5 Suzhou Lixinpharm Recent Development
    7.11 Lisheng Pharma
        7.11.1 Lisheng Pharma Company Information
        7.11.2 Lisheng Pharma Introduction and Business Overview
        7.11.3 Lisheng Pharma Indapamide Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 Lisheng Pharma Indapamide Product Offerings
        7.11.5 Lisheng Pharma Recent Development
    7.12 Apeloa Kangyu
        7.12.1 Apeloa Kangyu Company Information
        7.12.2 Apeloa Kangyu Introduction and Business Overview
        7.12.3 Apeloa Kangyu Indapamide Sales, Revenue and Gross Margin (2019-2024)
        7.12.4 Apeloa Kangyu Indapamide Product Offerings
        7.12.5 Apeloa Kangyu Recent Development

 8 Industry Chain Analysis
    8.1 Indapamide Industrial Chain
    8.2 Indapamide Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Indapamide Sales Model
        8.5.2 Sales Channel
        8.5.3 Indapamide Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Indapamide Market Trends
    Table 2. Indapamide Market Drivers & Opportunity
    Table 3. Indapamide Market Challenges
    Table 4. Indapamide Market Restraints
    Table 5. Global Indapamide Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Indapamide Revenue Market Share by Company (2019-2024)
    Table 7. Global Indapamide Sales Volume by Company (2019-2024) & (K MT)
    Table 8. Global Indapamide Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Indapamide Price by Company (2019-2024) & (USD/MT)
    Table 10. Key Manufacturers Indapamide Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Indapamide Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Indapamide
    Table 13. Global Indapamide Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Indapamide as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Indapamide Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Indapamide Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Indapamide Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Indapamide Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Indapamide Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Indapamide Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)
    Table 22. Global Indapamide Sales Volume by Type (2019-2024) & (K MT)
    Table 23. Global Indapamide Sales Volume by Type (2025-2030) & (K MT)
    Table 24. Global Indapamide Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Indapamide Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Indapamide Price by Type (2019-2024) & (USD/MT)
    Table 27. Global Indapamide Price by Type (2025-2030) & (USD/MT)
    Table 28. Global Indapamide Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Indapamide Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Indapamide Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Indapamide Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Indapamide Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Indapamide Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)
    Table 34. Global Indapamide Sales Volume by Application (2019-2024) & (K MT)
    Table 35. Global Indapamide Sales Volume by Application (2025-2030) & (K MT)
    Table 36. Global Indapamide Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Indapamide Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Indapamide Price by Application (2019-2024) & (USD/MT)
    Table 39. Global Indapamide Price by Application (2025-2030) & (USD/MT)
    Table 40. Global Indapamide Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Indapamide Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Indapamide Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Indapamide Sales Value by Region (2019-2024) & (%)
    Table 44. Global Indapamide Sales Value by Region (2025-2030) & (%)
    Table 45. Global Indapamide Sales Volume by Region (K MT): 2019 VS 2023 VS 2030
    Table 46. Global Indapamide Sales Volume by Region (2019-2024) & (K MT)
    Table 47. Global Indapamide Sales Volume by Region (2025-2030) & (K MT)
    Table 48. Global Indapamide Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Indapamide Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Indapamide Average Price by Region (2019-2024) & (USD/MT)
    Table 51. Global Indapamide Average Price by Region (2025-2030) & (USD/MT)
    Table 52. Key Countries/Regions Indapamide Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Indapamide Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Indapamide Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Indapamide Sales Volume, (2019-2024) & (K MT)
    Table 56. Key Countries/Regions Indapamide Sales Volume, (2025-2030) & (K MT)
    Table 57. Servier Company Information
    Table 58. Servier Introduction and Business Overview
    Table 59. Servier Indapamide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 60. Servier Indapamide Product Offerings
    Table 61. Servier Recent Development
    Table 62. Cigna Company Information
    Table 63. Cigna Introduction and Business Overview
    Table 64. Cigna Indapamide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 65. Cigna Indapamide Product Offerings
    Table 66. Cigna Recent Development
    Table 67. ANI Pharma Company Information
    Table 68. ANI Pharma Introduction and Business Overview
    Table 69. ANI Pharma Indapamide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 70. ANI Pharma Indapamide Product Offerings
    Table 71. ANI Pharma Recent Development
    Table 72. Mylan Company Information
    Table 73. Mylan Introduction and Business Overview
    Table 74. Mylan Indapamide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 75. Mylan Indapamide Product Offerings
    Table 76. Mylan Recent Development
    Table 77. Teva Company Information
    Table 78. Teva Introduction and Business Overview
    Table 79. Teva Indapamide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 80. Teva Indapamide Product Offerings
    Table 81. Teva Recent Development
    Table 82. Shandong Yinfeida Pharmaceutical Company Information
    Table 83. Shandong Yinfeida Pharmaceutical Introduction and Business Overview
    Table 84. Shandong Yinfeida Pharmaceutical Indapamide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 85. Shandong Yinfeida Pharmaceutical Indapamide Product Offerings
    Table 86. Shandong Yinfeida Pharmaceutical Recent Development
    Table 87. Taj Pharmaceuticals Company Information
    Table 88. Taj Pharmaceuticals Introduction and Business Overview
    Table 89. Taj Pharmaceuticals Indapamide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 90. Taj Pharmaceuticals Indapamide Product Offerings
    Table 91. Taj Pharmaceuticals Recent Development
    Table 92. Supra Chemicals Company Information
    Table 93. Supra Chemicals Introduction and Business Overview
    Table 94. Supra Chemicals Indapamide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 95. Supra Chemicals Indapamide Product Offerings
    Table 96. Supra Chemicals Recent Development
    Table 97. Glenmark Pharmaceuticals Company Information
    Table 98. Glenmark Pharmaceuticals Introduction and Business Overview
    Table 99. Glenmark Pharmaceuticals Indapamide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 100. Glenmark Pharmaceuticals Indapamide Product Offerings
    Table 101. Glenmark Pharmaceuticals Recent Development
    Table 102. Suzhou Lixinpharm Company Information
    Table 103. Suzhou Lixinpharm Introduction and Business Overview
    Table 104. Suzhou Lixinpharm Indapamide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 105. Suzhou Lixinpharm Indapamide Product Offerings
    Table 106. Suzhou Lixinpharm Recent Development
    Table 107. Lisheng Pharma Company Information
    Table 108. Lisheng Pharma Introduction and Business Overview
    Table 109. Lisheng Pharma Indapamide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 110. Lisheng Pharma Indapamide Product Offerings
    Table 111. Lisheng Pharma Recent Development
    Table 112. Apeloa Kangyu Company Information
    Table 113. Apeloa Kangyu Introduction and Business Overview
    Table 114. Apeloa Kangyu Indapamide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 115. Apeloa Kangyu Indapamide Product Offerings
    Table 116. Apeloa Kangyu Recent Development
    Table 117. Key Raw Materials Lists
    Table 118. Raw Materials Key Suppliers Lists
    Table 119. Indapamide Downstream Customers
    Table 120. Indapamide Distributors List
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Indapamide Product Picture
    Figure 2. Global Indapamide Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Indapamide Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Indapamide Sales Volume (2019-2030) & (K MT)
    Figure 5. Global Indapamide Sales Price (2019-2030) & (USD/MT)
    Figure 6. Indapamide Report Years Considered
    Figure 7. Global Indapamide Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Indapamide Players Sales Volume Ranking (2023) & (K MT)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Indapamide Revenue in 2023
    Figure 10. Indapamide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. 1.25 mg Indapamide Tablets Picture
    Figure 12. 2.5 mg Indapamide Tablets Picture
    Figure 13. Global Indapamide Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Indapamide Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Indapamide Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)
    Figure 16. Global Indapamide Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Indapamide Price by Type (2019-2030) & (USD/MT)
    Figure 18. Product Picture of Diuretic
    Figure 19. Product Picture of Hypertension Treatment
    Figure 20. Product Picture of Other
    Figure 21. Global Indapamide Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Indapamide Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Indapamide Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)
    Figure 24. Global Indapamide Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Indapamide Price by Application (2019-2030) & (USD/MT)
    Figure 26. North America Indapamide Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Indapamide Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Indapamide Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Indapamide Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Indapamide Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Indapamide Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Indapamide Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Indapamide Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Indapamide Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Indapamide Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Indapamide Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Indapamide Sales Volume (%), (2019-2030)
    Figure 38. United States Indapamide Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Indapamide Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Indapamide Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Indapamide Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Indapamide Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Indapamide Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Indapamide Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Indapamide Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Indapamide Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Indapamide Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Indapamide Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Indapamide Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Indapamide Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Indapamide Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Indapamide Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Indapamide Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Indapamide Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Indapamide Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Indapamide Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Indapamide Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Indapamide Sales Value by Application (%), 2023 VS 2030
    Figure 59. Indapamide Industrial Chain
    Figure 60. Indapamide Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed

Description

The global market for Indapamide was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Indapamide was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Indapamide was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Indapamide was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Indapamide include Servier, Cigna, ANI Pharma, Mylan, Teva, Shandong Yinfeida Pharmaceutical, Taj Pharmaceuticals, Supra Chemicals and Glenmark Pharmaceuticals, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Indapamide, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Indapamide by region & country, by Type, and by Application.

The Indapamide market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Indapamide.

Market Segmentation